• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Structured Product Labeling Resources

The Structured Product Labeling (SPL) is a document markup standard approved by Health Level Seven (HL7) and adopted by FDA as a mechanism for exchanging medication information.

SPL Documents

SPL Guidance and Supporting Documents

Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing (Draft)

  • Structured Product Labeling Implementation Guide for FDA Drug Establishment Registration and Drug Listing v1.0 (updated July 10, 2008) PDF
  • Structured Product Labeling Validation Procedures for Drug Establishment Registration and Drug Listing v1.0 PDF
  • Instructions for using Electronic Drug Establishment Registration and Drug Listing XForms v1.0 PDF
  • SPL Docket 92S-0251 - Drug Establishment Registration and Drug Listing

Guidance to industry: Providing Regulatory Submissions in Electronic Format -- Content of Labeling (Final)

Guidance for Industry: Indexing Structured Product Labeling (Final)

SPL Schema and Stylesheet

FDA SPL Schema for Implementation (zip file last updated July 10, 2008)

FDA SPL stylesheet (last updated October 15, 2008) - send comments to spl@fda.hhs.gov

Stylesheet Archive (zip file of older versions of the FDA SPL stylesheets)

 

Download Labels

FACTS@FDA

 

Resources

FDA Amendments Act of 2007 - Section 224 - Electronic Registration and Listing

HL7 RCRIM

SAX Parser

SPL Terminology

Terminology for Drug Establishment Registration and Drug Listing and Content of Labeling

Drug Registration and Drug Listing and Content of Labeling Terminology Lists in XML format - Downloadable file (zip file updated April 16, 2009)
Additional Validation Files - Downloadable file (zip file updated August 15, 2008) See "Structured Product Labeling Validation Procedures for Drug Establishment Registration and Drug Listing" for information on the use of the additional validation files.

Terminology for Indexing

Contact Information

Questions regarding SPL submissions should be directed to: spl@fda.hhs.gov.

HL7 SPL Implementation Workgroup: The HL7 SPL Implementation Workgroup is composed of spl vendors and members from the pharmaceutical industry, academia, HL7, FDA, and SPL developers who meet regularly to discuss issues regarding the SPL implementation in general and the SPL implementation guide. Membership in HL7 is not required to participate. For more information regarding the Workgroup, contact Terry Brunone (Terry Brunone).

For help accessing PDF, Word, Excel, and Zipped files, go to General Help for Accessing Files on this Web site.

 
-